D&O Insurance for Healthcare Organizations: Coverage Guide for Hospitals, Practices & Health Systems

Reading Time: 15 minutes

Healthcare directors and officers (D&O) insurance protects the personal assets of executives, board members, and trustees when they are sued over management decisions, regulatory matters, or alleged breaches of fiduciary duty. It is separate from medical malpractice coverage, which responds to patient-care claims against clinicians. D&O answers a different question entirely: who pays when a hospital board, a physician group’s managing partners, or a health system’s officers are personally named in a lawsuit.

Healthcare is now the single most-targeted sector for this kind of litigation. Securities class actions, regulatory investigations, and insolvency-driven fiduciary claims hit healthcare organizations harder than almost any other industry, and the dollar figures are steep. For context on what employees pay out of pocket, see our guides on dental filling costs without insurance and braces and Invisalign costs without insurance.

Why Healthcare Organizations Face Outsized D&O Exposure

The healthcare sector combines almost every risk factor that drives management liability claims into one operating environment. Heavy regulation, constant M&A, thin operating margins, and high employee turnover all converge on the people running these organizations.

• Regulatory scrutiny from the DOJ, OIG, CMS, and state agencies turns routine billing questions into formal investigations with six-figure defense costs.
• Merger and acquisition activity exposes boards to claims that a deal was mispriced, inadequately disclosed, or breached a duty to stakeholders.
• Financial pressure and insolvency in distressed systems trigger fiduciary-breach claims from creditors and bondholders.
• Employment practices disputes such as wrongful termination and discrimination frequently name directors and officers personally.
• Antitrust and competition reviews increasingly target hospital consolidation and physician-group roll-ups.

What Does Healthcare D&O Insurance Actually Cover?

A healthcare D&O policy responds to claims alleging wrongful acts by directors and officers in their leadership roles. The protection is built around three insuring agreements, and understanding how they differ is essential for any board evaluating its coverage.

Side A, B, and C Coverage Compared

Coverage Part	Who It Protects	When It Responds
Side A	Individual directors and officers	When the organization cannot indemnify them, such as during insolvency or where state law prohibits it
Side B	The healthcare organization	Reimburses the entity when it advances defense or settlement costs for its leaders
Side C	The entity itself	Securities claims for public companies; broader entity claims for private and nonprofit organizations

Healthcare-Specific Endorsements That Generic Policies Miss

Off-the-shelf D&O forms were written for ordinary corporations, not for organizations operating under HIPAA, EMTALA, and the False Claims Act. The gaps show up exactly when a healthcare organization needs the policy most.

• Regulatory and HIPAA defense: Covers the cost of responding to privacy investigations, billing audits, and False Claims Act inquiries.
• EMTALA and licensing proceedings: Protects officers facing administrative or licensure challenges tied to facility operations.
• Antitrust extension: Responds to competition claims arising from consolidation and network formation.
• Investigation cost coverage: Pays entity-level costs for regulatory inquiries before any formal claim is filed.

Coverage by Healthcare Organization Type

D&O exposure looks different depending on what kind of healthcare organization you run. A 400-bed hospital system, a 30-physician medical group, and a clinical-stage biotech each face a distinct claim profile, and each needs its policy structured accordingly.

• Hospitals and health systems carry the heaviest regulatory and M&A exposure. Learn more on our page covering D&O insurance for hospitals and health systems.
• Physician groups and medical practices face employment and partnership-dispute claims. See our guide to D&O insurance for physician groups and medical practices.
• Biotech and life sciences companies carry securities and disclosure exposure tied to trials and funding. Read about D&O insurance for biotech and life sciences companies.
• Managed care organizations and health plans face a payer-specific claim profile. Review our page on D&O insurance for managed care and health plans.

Healthcare organizations also rely on coverage that works alongside D&O, including core directors and officers insurance and broader management liability programs. For the people delivering care, our healthcare workers insurance solutions address professional exposures that sit outside the boardroom.

What Does Healthcare D&O Insurance Cost?

D&O pricing for healthcare organizations is driven far more by exposure profile than by size alone. The market is currently soft and competitive — D&O posted the largest decrease of any commercial line in late 2025 (about −3.8%, eighth straight quarterly decline) — which means well-governed healthcare organizations can lock in broad terms at favorable pricing right now, even as claim severity keeps rising. The factors that move your number:

• Organization type & asset size — a multi-entity health system carries far more board exposure than a single clinic.
• Regulatory footprint — Medicare/Medicaid billing, Stark/Anti-Kickback exposure, and multi-state operations all raise the number.
• Claims & litigation history — prior securities, antitrust, or regulatory actions are the single biggest multiplier.
• Governance quality — documented board processes, an audit committee, and compliance infrastructure lower it.
• Limit & retention selected — healthcare is the #1 litigated D&O sector (~30% of securities class actions), so limit adequacy is the real decision, not the premium line.

Relative Cost Positioning by Profile

Profile	Relative cost band	Primary cost driver
Single clinic / small practice	Lower band	Limited board, narrow regulatory exposure
Regional medical group / IPA	Mid band	Multi-site billing, employment exposure
Hospital / health system	Upper band	Asset size, antitrust, regulatory depth
Biotech / publicly traded	Highest variance	Securities exposure, clinical-trial risk

Directional, peer-relative positioning — not a quote. Actual premium depends on claims history, asset size, governance, and venue.

D&O Insurance for Hospitals and Health Systems: Board Protection

Hospitals and health systems carry the heaviest directors and officers (D&O) exposure in all of healthcare. Their boards make high-stakes decisions about mergers, bond financing, service-line closures, and regulatory compliance, and any one of those decisions can produce a lawsuit naming individual trustees and officers personally. D&O insurance is what stands between those leaders and their own personal assets when a claim lands.

For a hospital or multi-facility system, the question is rarely whether a claim will come. It is whether the policy is structured to absorb the regulatory investigations, fiduciary-breach suits, and antitrust reviews that target organizations of this size.

Why Do Hospitals Face Such High D&O Risk?

A hospital is one of the most heavily regulated, capital-intensive, and litigation-prone organizations a board can govern. The exposures stack on top of one another in ways few other industries experience.

• Federal and state regulators treat billing, coding, and reimbursement as enforcement priorities, and False Claims Act actions can name leadership directly.
• Bond-financed capital projects expose trustees to claims from bondholders if a system’s finances deteriorate.
• Service-line decisions, including closures and consolidations, draw claims from community stakeholders and employees.
• Large workforces produce a steady volume of employment-practices claims that frequently name officers.
• Merger activity invites allegations that a transaction was mispriced or inadequately disclosed.

What a Hospital D&O Policy Should Include

The structure of a hospital D&O program differs from a standard corporate policy in the extensions it carries. These are the provisions that determine whether the policy responds when a regulator or a creditor comes calling.

Exposure	Coverage Needed	Why It Matters for Hospitals
Regulatory investigation	Regulatory defense extension	DOJ/OIG/CMS inquiries carry heavy defense costs before any formal claim
Insolvency / bankruptcy	Robust Side A coverage	Protects individuals when the system cannot indemnify them
Consolidation	Antitrust extension	Responds to competition claims from mergers and network formation
Privacy breach	HIPAA defense coverage	Covers response costs for privacy investigations tied to board oversight

Hospital D&O coverage works alongside the broader healthcare D&O insurance framework and complements professional exposures addressed by our healthcare workers insurance solutions. Physician groups affiliated with a system face a different claim profile, covered on our page about D&O insurance for physician groups and medical practices.

What Does Hospital & Health System D&O Cost?

D&O pricing for healthcare organizations is driven far more by exposure profile than by size alone. The market is currently soft and competitive — D&O posted the largest decrease of any commercial line in late 2025 (about −3.8%, eighth straight quarterly decline) — which means well-governed healthcare organizations can lock in broad terms at favorable pricing right now, even as claim severity keeps rising. The factors that move your number:

• Net patient revenue & total assets — the primary sizing input for hospital towers.
• Antitrust exposure — affiliations, mergers, and physician-acquisition activity drive the highest-severity claims.
• Regulatory profile — 340B, Medicare/Medicaid billing, and EMTALA exposure.
• Board composition & governance maturity — independent directors and a functioning audit committee lower cost.
• Prior claims — any past regulatory or securities action is the dominant multiplier.

Relative Cost Positioning by Profile

Profile	Relative cost band	Primary cost driver
Community hospital (single site)	Lower–mid band	Asset size, local regulatory exposure
Multi-hospital system	Upper band	Antitrust, multi-state regulatory depth
Academic medical center	Upper band	Research, clinical-trial, and grant exposure
System in active M&A	Highest variance	Antitrust + transaction exposure

Directional, peer-relative positioning — not a quote. Actual premium depends on claims history, asset size, governance, and venue.

D&O Insurance for Physician Groups and Medical Practices: Partner Protection

Physician groups and medical practices need directors and officers (D&O) insurance to protect the managing partners and officers who run the business side of the practice. When a group is sued over a partnership dispute, a wrongful termination, an employment claim, or a contract disagreement, those claims often name the physician-leaders personally. D&O insurance protects their personal assets in a way that medical malpractice coverage simply does not.

As independent practices consolidate and physician groups grow into multi-site organizations with real management structures, the management-liability exposure grows with them. The larger and more sophisticated the group, the more its leaders look like corporate officers in the eyes of a plaintiff.

What D&O Claims Do Medical Practices Actually Face?

Unlike publicly traded healthcare companies, physician groups rarely face securities litigation. Their claims come from people they work with day to day, and that changes how the policy should be built. For context on what employees pay out of pocket, see our guides on dental filling costs without insurance and braces and Invisalign costs without insurance.

• Employees alleging wrongful termination, discrimination, or harassment, which name both the practice and its officers.
• Partners in dispute over compensation formulas, equity buy-ins, or governance decisions.
• Departing physicians contesting non-compete or restrictive covenant enforcement.
• Vendors and payers alleging breach of contract or improper business practices.
• Regulatory inquiries into billing or coding that name practice leadership.

D&O vs. Malpractice vs. EPLI for Medical Groups

Physician groups carry several liability policies that are easy to confuse. Each one answers a different kind of claim, and a gap in any of them can leave the practice or its partners exposed.

Policy	Responds To	Example Claim
D&O	Management decisions	Partner sues over a governance or compensation decision
Medical malpractice	Patient care	Patient alleges a treatment error
EPLI	Employment practices	Former employee alleges wrongful termination

Physician group D&O sits within the broader healthcare D&O insurance framework. Physicians transitioning between employment and practice ownership also face individual exposures we cover for healthcare workers. Groups affiliated with a larger system should also review D&O insurance for hospitals and health systems.

What Does Physician Group & Medical Practice D&O Cost?

D&O pricing for healthcare organizations is driven far more by exposure profile than by size alone. The market is currently soft and competitive — D&O posted the largest decrease of any commercial line in late 2025 (about −3.8%, eighth straight quarterly decline) — which means well-governed healthcare organizations can lock in broad terms at favorable pricing right now, even as claim severity keeps rising. The factors that move your number:

• Group size & number of owners — more partners means more management-decision exposure.
• Employment practices — physician and staff disputes are the most common claim type for groups.
• Billing & coding exposure — Medicare/Medicaid audit and False Claims Act risk.
• Practice activity — mergers, private-equity transactions, and de novo expansion raise exposure.
• Whether D&O, EPLI, and malpractice are coordinated — gaps between them are where uninsured claims land.

Relative Cost Positioning by Profile

Profile	Relative cost band	Primary cost driver
Solo / 2–3 physician practice	Lower band	Limited management exposure
Mid-size group (10–30 physicians)	Mid band	Employment + billing exposure
Large group / IPA	Upper band	Governance complexity, PE activity
Group in PE transaction	Highest variance	Transaction + representation exposure

Directional, peer-relative positioning — not a quote. Actual premium depends on claims history, asset size, governance, and venue.

D&O Insurance for Biotech and Life Sciences: Securities and Disclosure Risk

Biotech and life sciences companies face some of the most severe directors and officers (D&O) exposure in healthcare. A single disappointing trial readout, a delayed FDA decision, or an aggressive claim about a platform’s potential can trigger a securities class action that names the entire executive team and board. For clinical-stage and newly public companies, D&O insurance is not optional. Investors and underwriters expect it, and the personal exposure without it is enormous.

What makes life sciences distinct is the volatility. Stock prices move sharply on binary events, and any large move downward draws plaintiff firms looking for a disclosure they can challenge.

Why Are Life Sciences Companies Sued So Often?

The biotech business model concentrates enormous value in a handful of uncertain outcomes, and that concentration is what attracts litigation. When the outcome disappoints, the lawsuit usually follows.

• Clinical trial results that miss expectations and send the stock down sharply.
• FDA decisions, including delays, rejections, and complete response letters, that surprise investors.
• Disclosure disputes over how a company characterized its data, pipeline, or commercial prospects.
• Statements about AI-driven drug discovery that plaintiffs allege were overstated.
• Funding and IPO representations that later face scrutiny if performance falls short.

How D&O Cost and Structure Change by Company Stage

A life sciences company’s D&O needs evolve dramatically as it moves from private research to a public listing. The exposure, the limits, and the premium all shift at each stage.

Stage	Primary Exposure	Coverage Priority
Private / clinical-stage	Investor and employment claims	Private company D&O with funding-round protection
Pre-IPO	Disclosure and offering exposure	IPO-ready program and prospectus review
Public	Securities class actions	Full Side A/B/C towers with adequate excess layers

Life sciences D&O sits within the broader healthcare D&O insurance framework. Companies with significant technology platforms should also review their cyber liability coverage, since cyber events increasingly drive board-level claims. Larger organizations can compare exposures on our page covering hospital and health system D&O insurance.

D&O Insurance for Managed Care Organizations and Health Plans

Managed care organizations and health plans face a directors and officers (D&O) risk profile unlike any other healthcare entity. As payers, they make coverage and reimbursement decisions that directly affect patients and providers, and those decisions generate claims that target the organization’s leadership. D&O insurance, often paired with managed care errors and omissions coverage, protects the directors and officers of health plans, MSOs, and payer organizations when those decisions are challenged.

The defining feature here is that the organization’s core business activity, deciding what care gets paid for, is itself a source of liability. That puts managed care leadership in a position few other executives occupy.

What Claims Do Managed Care Organizations Face?

Health plans sit at the intersection of patients, providers, employers, and regulators, and each of those relationships can produce a claim against leadership. The exposures are specific to the payer role.

• Coverage and benefit denial disputes brought by members or their representatives.
• Provider claims over reimbursement rates, network exclusion, or contract terminations.
• Regulatory actions from state insurance departments and federal agencies.
• Employer-group disputes over plan administration and performance.
• Employment and management claims common to any large organization.

D&O and E&O: Why Managed Care Needs Both

For a payer, the line between a management decision and a professional service is thin, which is why managed care organizations rarely rely on D&O alone. The two coverages work together to close the gap.

Coverage	What It Addresses	Managed Care Example
D&O	Management and governance decisions	Board sued over a strategic or financial decision
Managed care E&O	Professional payer activities	Member challenges a coverage or utilization decision
Combined program	Both, coordinated	A dispute alleging both a governance failure and a wrongful denial

Managed care D&O sits within the broader healthcare D&O insurance framework. Payers with significant data operations should also review their cyber liability coverage. Provider organizations contracting with health plans can compare their own exposure on our pages covering hospital and health system D&O and physician group D&O insurance.